HUT51892A - Process for production of bubbling medical compositions containing ibupuphen - Google Patents

Process for production of bubbling medical compositions containing ibupuphen

Info

Publication number
HUT51892A
HUT51892A HU895858A HU585889A HUT51892A HU T51892 A HUT51892 A HU T51892A HU 895858 A HU895858 A HU 895858A HU 585889 A HU585889 A HU 585889A HU T51892 A HUT51892 A HU T51892A
Authority
HU
Hungary
Prior art keywords
ibupuphen
bubbling
production
compositions containing
medical compositions
Prior art date
Application number
HU895858A
Other languages
English (en)
Other versions
HU895858D0 (en
HU202103B (en
Inventor
Christian Fritsch
Werner Grawingholt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6367061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT51892(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HU895858D0 publication Critical patent/HU895858D0/hu
Publication of HUT51892A publication Critical patent/HUT51892A/hu
Publication of HU202103B publication Critical patent/HU202103B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU895858A 1988-11-12 1989-11-10 Process for producing effervescent pharmaceutical compositions containing ibuprofen HU202103B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3838431A DE3838431A1 (de) 1988-11-12 1988-11-12 Ibuprofen-brausezubereitungen

Publications (3)

Publication Number Publication Date
HU895858D0 HU895858D0 (en) 1990-02-28
HUT51892A true HUT51892A (en) 1990-06-28
HU202103B HU202103B (en) 1991-02-28

Family

ID=6367061

Family Applications (2)

Application Number Title Priority Date Filing Date
HU895858A HU202103B (en) 1988-11-12 1989-11-10 Process for producing effervescent pharmaceutical compositions containing ibuprofen
HU95P/P00647P HU211692A9 (en) 1988-11-12 1995-06-30 Effervescent ibuprofen preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00647P HU211692A9 (en) 1988-11-12 1995-06-30 Effervescent ibuprofen preparations

Country Status (12)

Country Link
US (1) US5445827A (hu)
EP (1) EP0369228B1 (hu)
JP (1) JP2735903B2 (hu)
AT (1) ATE70438T1 (hu)
AU (1) AU616066B2 (hu)
CA (1) CA2002732A1 (hu)
DE (2) DE3838431A1 (hu)
ES (1) ES2028430T3 (hu)
FI (1) FI895342A0 (hu)
GR (1) GR3003685T3 (hu)
HU (2) HU202103B (hu)
PT (1) PT92271B (hu)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5922351A (en) * 1991-03-27 1999-07-13 Bayer Corporation Lubricants for use in tabletting
US6525214B1 (en) 1991-05-13 2003-02-25 Bernard John Armitage Therapeutic agent
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
DK0642784T3 (da) 1993-09-07 1999-11-22 Gergely Gerhard Bruseblanding med alkalisalte eller lysinater af uopløseligt eller tungtopløseligt aktivstof
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
GB9426218D0 (en) * 1994-12-23 1995-02-22 Procter & Gamble Processes of preparing pharmaceutical compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
DE19606151C2 (de) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
ITMI20020557A1 (it) * 2002-03-15 2003-09-15 Acraf Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
US7862833B2 (en) * 2003-12-31 2011-01-04 Cima Labs, Inc. Effervescent oral opiate dosage forms and methods of administering opiates
WO2005065317A2 (en) * 2003-12-31 2005-07-21 Cima Labs Inc. Effervescent oral fentanyl dosage form
US20050142197A1 (en) * 2003-12-31 2005-06-30 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
AU2006226293B2 (en) * 2005-03-22 2011-04-07 Losan Pharma Gmbh Solubilized ibuprofen
EP1905428A1 (de) * 2006-09-26 2008-04-02 Losan Pharma GmbH Ibuprofen-Brausezubereitung mit hoher Lösungsgeschwindigkeit und Verfahren zu deren Herstellung
US9629806B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
PT2953617T (pt) * 2013-02-06 2020-01-14 Hermes Arzneimittel Gmbh Composições farmacêuticas que incorporam fármacos de baixa dose
EP3157506B1 (en) 2014-06-20 2020-08-26 Hermes Arzneimittel GmbH Taste-masked oral pharmaceutical composition
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions
GB2546513B (en) * 2016-01-20 2020-09-16 Cubic Pharmaceuticals Ltd Process of preparing active pharmaceutical ingredient salts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
DE3270988D1 (en) * 1981-07-20 1986-06-12 Upjohn Co Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen

Also Published As

Publication number Publication date
EP0369228B1 (de) 1991-12-18
ATE70438T1 (de) 1992-01-15
EP0369228A1 (de) 1990-05-23
FI895342A0 (fi) 1989-11-09
DE3838431A1 (de) 1990-05-17
US5445827A (en) 1995-08-29
AU616066B2 (en) 1991-10-17
PT92271A (pt) 1990-05-31
PT92271B (pt) 1995-08-09
AU4441789A (en) 1990-05-17
CA2002732A1 (en) 1990-05-12
DE58900594D1 (de) 1992-01-30
JP2735903B2 (ja) 1998-04-02
GR3003685T3 (hu) 1993-03-16
HU895858D0 (en) 1990-02-28
HU211692A9 (en) 1995-12-28
HU202103B (en) 1991-02-28
JPH02178223A (ja) 1990-07-11
ES2028430T3 (es) 1992-07-01

Similar Documents

Publication Publication Date Title
HU895858D0 (en) Process for production of bubbling medical compositions containing ibupuphen
ZA875947B (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid
GB2192131B (en) Pharmaceutical compositions containing calcium salts.
IL66256A0 (en) Water containing compositions comprising salts of n-substituted-2-pyrrolidone-4-carboxylic acids as humectants
DK0673245T3 (da) Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
NZ237710A (en) Composition comprising amoxycillin hydrate and an effervescent couple containing sufficient excess alkaline component to provide a clear solution
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
CA2009326A1 (en) Aqueous granulation solution and a method of tablet granulation
IL78431A0 (en) Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid and salts thereof,their production and pharmaceutical compositions containing them
AU2908189A (en) Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases
PH25512A (en) Piperazinecarboxylic acid, pharmaceutical compositions containing it
AU570446B2 (en) Dipyridamole controlled release compositon
PT83472A (en) Process for preparing improved antiinflammatory compositions containing piroxicam
HUT56498A (en) Process for producing pharmaceutical compositions having antiviral effect, containing benzylphosphonic acid derivatives
GB1475861A (en) Pharmaceutical composition
GR3002449T3 (en) Fitness drink powder
NZ216111A (en) 4(z)-6-((2,4,5-cis -4-o-hydroxyphenyl-2-trifluoro-methyl-1,3-dioxan-5-yl) hexanoic acid, pharmaceutical salts and pharmaceutical compositions thereof; ethers thereof
HUT59593A (en) Process for producing pharmaceutical composition
MY110050A (en) A process for the production of a stable mixture of n- (phosphonomethyl) glycine isopropylamine and methylchlorophenoxyacetic acid isopropylamine

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee
HRH9 Withdrawal of annulment decision
HMM4 Cancellation of final prot. due to non-payment of fee